With 10.8% CAGR, Opioid Use Disorder (OUD) Market Size to Touch USD 4.50 billion by 2026 | Global Market Share

The global opioid use disorder (OUD) market size is projected to reach USD 4.50 billion by 2026, exhibiting a CAGR of 10.8% during the forecast period. Increasing addiction to opioids across the globe will be the central force driving the growth of this market, shares Fortune Business Insights™ in its recent report, titled “Opioid Use Disorder (OUD) Market Size, Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2019-2026”.
Highlights of the Report:

• In-depth analysis of various insights, namely, Opioid Use Disorder (OUD) Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and Opioid Use Disorder (OUD) Market share.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/opioid-use-disorder-oud-market-102674

Key Players Operating in The Opioid Use Disorder (OUD) Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Camurus
• Pfizer Inc.
• BioDelivery Sciences International Inc.
• TEVA PHARMACEUTICALS USA, INC
• Orexo US, Inc.
• Indivior PLC
• Hikma Pharmaceuticals
• Mylan
• Mallinckrodt.
• Titan Pharmaceuticals Inc.
• Alkermes
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/opioid-use-disorder-oud-market-102674
Detailed Table of Content:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Pipeline Analysis
4.2. New Product Launches
4.3. Statistics of Opioid Use Disorder
4.4. Industry Developments Such as Mergers, Acquisitions, and Collaborations
5. Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Drug Class
5.2.1. Buprenorphine
5.2.2. Methadone
5.2.3. Naltrexone
5.3. Market Analysis, Insights and Forecast – By Route of Administration
5.3.1. Oral
5.3.2. Parenteral
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Hospitals Pharmacies
5.4.2. Retail Pharmacies & Stores
5.4.3. Online Pharmacies
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Rest of the World
6. North America Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Drug Class
6.2.1. Buprenorphine
6.2.2. Methadone
6.2.3. Naltrexone
6.3. Market Analysis – By Route of Administration
6.3.1. Oral
6.3.2. Parenteral
6.4. Market Analysis – By Distribution Channel
6.4.1. Hospitals Pharmacies
6.4.2. Retail Pharmacies & Stores
6.4.3. Online Pharmacies
6.5. Market Analysis – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Drug Class
7.2.1. Buprenorphine
7.2.2. Methadone
7.2.3. Naltrexone
7.3. Market Analysis – By Route of Administration
7.3.1. Oral
7.3.2. Parenteral
7.4. Market Analysis – By Distribution Channel
7.4.1. Hospitals Pharmacies
7.4.2. Retail Pharmacies & Stores
7.4.3. Online Pharmacies
7.5. Market Analysis – By Country/ sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Drug Class
8.2.1. Buprenorphine
8.2.2. Methadone
8.2.3. Naltrexone
8.3. Market Analysis – By Route of Administration
8.3.1. Oral
8.3.2. Parenteral
8.4. Market Analysis – By Distribution Channel
8.4.1. Hospitals Pharmacies
8.4.2. Retail Pharmacies & Stores
8.4.3. Online Pharmacies
8.5. Market Analysis – By Country
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Rest of the World Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Drug Class
9.2.1. Buprenorphine
9.2.2. Methadone
9.2.3. Naltrexone
9.3. Market Analysis – By Route of Administration
9.3.1. Oral
9.3.2. Parenteral
9.4. Market Analysis – By Distribution Channel
9.4.1. Hospitals Pharmacies
9.4.2. Retail Pharmacies & Stores
9.4.3. Online Pharmacies
10. Competitive Analysis
10.1. Key Industry Developments
10.2. Global Market Share Analysis (2017)
10.3. Competition Dashboard
10.4. Comparative Analysis – Major Players
10.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
10.5.1. Indivior PLC
10.5.2. Alkermes
10.5.3. Orexo US, Inc.
10.5.4. Titan Pharmaceuticals Inc.
10.5.5. TEVA PHARMACEUTICALS USA, INC
10.5.6. Mallinckrodt
10.5.7. BioDelivery Sciences International Inc.
10.5.8. Mylan
10.5.9. Pfizer Inc.
10.5.10. Hikma Pharmaceuticals
10.5.11. Camurus
10.5.12. Other Prominent Players
Continued...

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.